JUNS: Jupiter Neurosciences P/E multiplikatori
Jupiter Neurosciences Inc (JUNS) FDA ning qat'iy nazoratiga qaramay, miyaga dori yetkazib berish texnologiyalari uchun mustahkam patent himoyasiga va AQSh ilmiy hamjamiyati ichida sezilarli ta'sirga ega. Brend inqilobiy neyroprotektiv agentlarni ishlab chiqqani uchun tan olinishga loyiq ko'rildi. Ushbu narxlar grafigi -0.30 miqdoridagi P/E koeffitsiyentini aks ettiradi. Kompaniyaning istiqbollari to'liq miqyosdagi klinik sinovlarga o'tish va yangi grantlarni izlashga bog'liq.
Jupiter Neurosciences Inc (JUNS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Jamlagan qarzning kapitalga nisbati Jupiter Neurosciences Inc|JUNS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati jupiterneurosciences.com|JUNS - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Jupiter Neurosciences Inc|JUNS - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Jupiter Neurosciences|Shoshilinch likvidlik koeffitsiyenti jupiterneurosciences.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
JUNS - Sof foyda|Kutilayotgan sof foyda Jupiter Neurosciences Inc|JUNS - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori Jupiter Neurosciences, Inc.|JUNS - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Jupiter Neurosciences Inc|JUNS - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Jupiter Neurosciences|JUNS - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi jupiterneurosciences.com|JUNS - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Jupiter Neurosciences Inc
Kompaniyaning har tomonlama tahlili:Jupiter Neurosciences, Inc. - JUNS
Investorlar Jupiter Neurosciences Inc (JUNS) barqarorligini P/E koeffitsienti orqali baholamoqdalar, u investitsiyalarning qoplanish muddatini aniqlash uchun bozor kapitalizatsiyasini sof foydaga nisbatlaydi. Jupiter Neurosciences Inc (JUNS) ning nisbiy P/E baholashini tahlil qilish orqali, bozor neyrobiologlarning ixcham jamoasi samaradorligini qanchalik darajada hisobga olayotganini tushunish mumkin, ularning sadoqati va Altsgeymer kasalligi terapiyasi bo'yicha ilmiy salohiyati biznesning fundamental qiymatini belgilaydi.
Raqobatdosh kompaniyalar
BIIB (biogen.com) - Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti NBIX (Neurocrine Biosciences, Inc.)|P/E multiplikatori Regencell Bioscience Ltd (RGC)|Narxning foydaga nisbati Axsome Therapeutics Inc AXSM|ACAD (ACADIA Corp) - Kapitalizatsiyaning sof foydaga nisbati|Xenon Pharmaceuticals - P/E multiplikatori|Biznesning o‘zini qoplash muddati vikingtherapeutics.com VKTX|SUPN (Supernus) - Narx-foyda koeffitsiyenti|CPRX: Bozor narxining sof foydaga nisbati|DNLI (Denali Therapeutics Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Harmony Corp HRMY|Narxning foydaga nisbati Biohaven Ltd. (BHVN)|AMLX (amylyx.com) - Kompaniya qiymatining sof foydaga nisbati|Trevi Therapeutics, Inc. - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PRAX|AVXL - Narxning foydaga nisbati|CBLL (CeriBell EEG) - Narx-foyda multiplikatori|PRTA: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Alector (ALEC)|Narx-foyda koeffitsiyenti ANNX|P/E multiplikatori Omeros Corp.|Narxning foydaga nisbati Neurogene Corp (NGNE)|ACIU (AC Immune Inc) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Voyager Therapeutics VYGR|neumoratx.com (NMRA) - Kapitalizatsiyaning foydaga nisbati|SCLX - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Tevogen Bio Holdings Inc. TVGN|ACOG: P/E multiplikatori|Narx-foyda koeffitsiyenti Cognition Therapeutics Inc.|IKT (Inhibikase Therapeutics) - P/E multiplikatori|cassavasciences.com (SAVA) - Biznesning o‘zini qoplash muddati|P/E multiplikatori ASRT|COYA - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Vistagen VTGN|OVID: Narx-foyda multiplikatori|Acumen Pharmaceuticals - P/E multiplikatori|cervomed.com (CRVO) - Narx-foyda koeffitsiyenti|ATHE: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Clene (CLNN)|Narxning foydaga nisbati PepGen Inc|Relmada Corp (RLMD) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti ANVS (Annovis Bio, Inc.)|GRCE (gracetx.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AIFF (Firefly Neuroscience)|Biznesning o‘zini qoplash muddati ANEW Medical (KLTO)|NRSN - Narxning foydaga nisbati|RVPH (Reviva Pharmaceuticals, Inc.) - Narx-foyda multiplikatori|MTVA: P/E multiplikatori|Narx-foyda koeffitsiyenti neuraxis.com|Narxning foydaga nisbati Helius Medical Technologies, Inc.|PASG (Passage Bio Corp) - Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti NEUP (Neuphoria Therapeutics Inc.)|P/E multiplikatori Minerva (NERV)|Narxning foydaga nisbati Athira Pharma, Inc. ATHA|ADXN: Narx-foyda multiplikatori|ALZN - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Cyclerion Therapeutics CYCN|protagenic.com (PTIX) - Narxning foydaga nisbati|Narx-foyda multiplikatori KTTA|CRGT (Cortigent Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati avenuetx.com ATXI|Narx-foyda koeffitsiyenti BCLI (BrainStorm Cell Therapeutics)|P/E multiplikatori Cara Therapeutics Inc. (CARA)|Narxning foydaga nisbati Chromocell Therapeutics Corporation CHRO|Kompaniya qiymatining sof foydaga nisbati ELYM|ITCI - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati longboardpharma.com|Marinus Pharmaceuticals, Inc. (MRNS) - Narxning foydaga nisbati|NKGN: Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti NRBO|P/E multiplikatori Sage Therapeutics Inc|Narxning foydaga nisbati Synaptogenix, Inc. (SNPX)|TRVN: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori VIGL (Vigil Neuroscience, Inc.)|Biznesning o‘zini qoplash muddati anewmeds.com (WENA)|CERE: Narx-foyda koeffitsiyenti
